Call
Chat for Appointment
Patient Reports / LoginAicar Transformylase/Imp Cyclohydrolase Deficiency: Causes & Treatment
Written by Medicover Team and Medically Reviewed by Dr Rashmi Devaraj , Pediatric Neurologists
Table of Contents
AICAR transformylase/IMP cyclohydrolase deficiency is a rare genetic disorder that affects the body's ability to break down certain substances. This condition is caused by mutations in the ATIC gene, which plays a crucial role in a metabolic pathway involved in purine synthesis.
When this gene does not function properly, it can lead to a buildup of toxic substances in the body, causing various health problems. These mutations are typically inherited in an autosomal recessive pattern, meaning both parents must pass on the faulty gene for the condition to develop.
- Affects purine metabolism and nucleotide production.
- Leads to accumulation of toxic metabolic intermediates.
- Inherited in an autosomal recessive pattern.
- Can impact neurological and physical development.
Types of AICAR Transformylase/Imp Cyclohydrolase Deficiency
This condition is classified into two main types based on the symptoms and systems affected.
The first type is mainly neurological, while the second primarily affects the muscles. Both types involve impaired purine biosynthesis and accumulation of harmful metabolites.
- Type 1: Severe neurological symptoms such as developmental delay, seizures, and intellectual disability.
- Type 2: Muscle-related symptoms including weakness, exercise intolerance, and myopathy.
- Both types are linked to defective purine metabolism.
- Early identification helps in better symptom management.
What Are the Symptoms of Aicar Transformylase/Imp Cyclohydrolase Deficiency?
AICAR transformylase/IMP cyclohydrolase deficiency can present with a wide range of neurological and physical symptoms. These symptoms often appear early in life and may vary in severity.
Patients may also experience feeding difficulties, failure to thrive, abnormal liver function, and an increased risk of infections.
- Severe developmental delay in affected individuals.
- Neurological symptoms such as seizures and intellectual disability.
- Low muscle tone and muscle weakness.
- Difficulty with coordination and movement.
- Feeding difficulties and poor growth.
- Cardiac abnormalities, including congenital heart defects.
What Are the Causes of Aicar Transformylase/Imp Cyclohydrolase Deficiency?
This enzyme plays a crucial role in the purine nucleotide biosynthesis pathway. Its deficiency leads to impaired purine synthesis, causing the accumulation of toxic intermediates and reduced production of essential nucleotides.
The exact triggers of these mutations are not fully understood, and further research is required to determine the underlying mechanisms.
- Genetic mutations in the ATIC gene affecting enzyme function.
- Impaired purine synthesis leading to metabolic imbalance.
- Possible interference from certain medications such as methotrexate.
- Associated metabolic disorders disrupting purine pathways.
- Environmental exposure to toxins that may affect enzyme activity.
When Should You See a Doctor for Aicar Transformylase/Imp Cyclohydrolase Deficiency?
Early medical consultation is important if symptoms such as developmental delay, seizures, or muscle weakness are observed. Timely evaluation can help in early diagnosis and better management.
- Consult a pediatrician for early developmental concerns.
- Neurologists manage seizures and neurological symptoms.
- Genetic specialists help confirm inherited conditions.
- Metabolic disorder specialists guide long-term management.
Find Pediatric-neurologists for Aicar Transformylaseimp Cyclohydrolase Deficiency Treatment Near You
How is Aicar Transformylase/Imp Cyclohydrolase Deficiency Diagnosed?
Diagnosis involves a combination of clinical evaluation, laboratory testing, and genetic analysis. Symptoms such as developmental delay, seizures, and intellectual disability often prompt further investigation.
- Genetic testing to identify mutations in the ATIC gene.
- Blood tests showing elevated metabolic markers.
- Urine tests detecting increased excretion of AICAR and related compounds.
- Biochemical tests assessing purine metabolism abnormalities.
- Molecular testing to confirm diagnosis.
What Are the Treatment Options for Aicar Transformylase/Imp Cyclohydrolase Deficiency?
Treatment focuses on managing symptoms and preventing complications through a multidisciplinary approach. Care is usually personalized based on the severity and presentation of the condition.
- Dietary modifications to support metabolic balance.
- Supplementation with nutrients such as folinic acid.
- Management of neurological symptoms and developmental delays.
- Regular monitoring by metabolic disorder specialists.
- Consideration of experimental therapies such as gene therapy in selected cases.
Your health is everything - prioritize your well-being today.
Consult Aicar Transformylaseimp Cyclohydrolase Deficiency Doctors Today
What is the Recovery Process for Aicar Transformylase/Imp Cyclohydrolase Deficiency?
The recovery process varies depending on the severity of the condition. While there is no definitive cure, ongoing management can help improve quality of life and reduce complications.
- Regular follow-ups to monitor disease progression.
- Supportive therapies such as physiotherapy and occupational therapy.
- Long-term nutritional and metabolic management.
- Early intervention programs for developmental support.
Frequently Asked Questions
1. How do I recognize the signs of AICAR transformylase/IMP cyclohydrolase deficiency?
Look for symptoms like developmental delay, seizures, muscle weakness, poor growth. Genetic testing can confirm the diagnosis.
2. What precautions should be taken for AICAR transformylase/IMP cyclohydrolase deficiency?
Avoid fasting and follow a diet rich in carbohydrates to manage symptoms of AICAR transformylase/IMP cyclohydrolase deficiency.
3. What are the potential complications of AICAR transformylase/IMP cyclohydrolase deficiency?
Potential complications of AICAR transformylase/IMP cyclohydrolase deficiency may include severe anemia and neurological problems.
4. What are the best ways to manage AICAR transformylase/IMP cyclohydrolase deficiency?
Treatment includes avoiding triggers like fasting, infections, and stress, along with medications to manage symptoms. Regular monitoring is important.
5. Is AICAR transformylase/IMP cyclohydrolase deficiency likely to come back after treatment?
Yes, AICAR transformylase/IMP cyclohydrolase deficiency may reoccur after treatment due to its genetic nature. Regular monitoring is important.
